Company Monitoring Page for Janssen

latest headlines for company on cafepharma

Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
Thu, 05/25/23 - 12:48 pm
Tags:
JNJ, Janssen, Tremfya, psoriasis, real world data
Janssen’s Tremyfa scores success in Phase III ulcerative colitis trial
Clinical Trials Arena
Wed, 05/10/23 - 10:02 am
Tags:
JNJ, Janssen, clinical trials, Tremyfa, ulcerative colitis
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
Tags:
JNJ, Janssen, Cellular Biomedicine, CAR-T, diffuse large B-cell lymphoma
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Tue, 04/25/23 - 10:28 am
Tags:
Genmab, JNJ, Janssen, Darzalex
J&J claims first approval for PARP combo Akeega
Pharmaphorum
Mon, 04/24/23 - 10:22 am
Tags:
JNJ, Janssen, Akeega, PARP inhibitors, metastatic castration-resistant prostate cancer, Europe
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
Tue, 04/18/23 - 10:13 am
Tags:
JNJ, Janssen, earnings, restructuring, infectious disease
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
Fri, 03/3/23 - 11:56 am
Tags:
JNJ, patents, Janssen, Amgen, biosimilars, Stelara
After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year
Fierce Biotech
Mon, 02/27/23 - 10:09 am
Tags:
JNJ, Janssen, nipocalimab, Momenta Pharmaceuticals
Janssen Returns Phase I NASH Candidate to Arrowhead
BioSpace
Wed, 02/15/23 - 06:08 pm
Tags:
JNJ, Janssen, RNAi, Arrowhead Pharmaceuticals, NASH
Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics
BioSpace
Thu, 02/9/23 - 10:53 am
Tags:
Roche, Janssen, JNJ, companion diagnostics, diagnostics
J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout
Endpoints
Mon, 02/6/23 - 10:41 am
Tags:
JNJ, Momenta, Janssen, nipocalimab, clinical trials
Janssen laying off 4 dozen employees as California plant heads toward closure
Fierce Pharma
Thu, 02/2/23 - 10:59 pm
Tags:
JNJ, Janssen, layoffs, California, drug manufacturing, Doxil, Concerta
Morphic Loses Another Big Pharma as J&J Bails on Research Deal
BioSpace
Mon, 01/23/23 - 11:13 am
Tags:
JNJ, Janssen, Morphic Therapeutic, R&D
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
Tags:
antibody-drug conjugate, Merck, LegoChem Biosciences, Mersana, Amgen, GSK, Janssen
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
Tags:
ASH 2022, AstraZeneca, Janssen, Merck, Vega Therapeutics
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
BioSpace
Mon, 12/5/22 - 10:59 am
Tags:
Horizon Therapeutics, M&A, Agmen, Sanofi, Janssen, JNJ
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
Tags:
JNJ, Janssen, Amgen, legal, ulcerative colitis, patents, Stelara
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
Thu, 12/1/22 - 10:33 am
Tags:
JNJ, AC Immune, Alzheimer's disease, Janssen, vaccines, ACI-35.030
Janssen’s Phase IIIb major depressive disorder trial meets primary endpoint
Clinical Trials Arena
Sat, 11/26/22 - 07:17 pm
Tags:
Janssen, JNJ, clinical trials, Spravato, treatment-resistant depression
Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues
BioSpace
Mon, 10/31/22 - 04:14 pm
Tags:
Essa Pharma, Janssen, JNJ, prostate cancer, clinical trials, EPI-7386

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.